Personalized Medicine · 2013 · 13 citations · 34 references
MedicineEndocrinologyOncologyMolecular OncologyNeoplasiaTumor ProgressionAngiogenesisCancer Molecular PathologyEndocrine TumorsMolecular Tumor ProfilingPituitary TumorsTumor MarkersAngiogenic BiomarkersPituitary Tumor Growth PatternsPituitary Tumor ImmunohistochemistryPituitary Tumor Molecular BiologyPituitary Tumor PathogenesisTissue Expression ProfilesTumor Growth DynamicsTumor Growth Monitoring
AIM: Pituitary adenomas are typically slow-growing and histologically benign tumors that can occasionally behave in a malignant-like manner, invading adjacent structures or recurring after treatment. Using protein analysis methods and multiplex xMAP assays, we aimed to find out if these particular types of tumors express angiogenic markers VEGF and basic FGF (bFGF), which are associated with tumor growth and invasiveness, and quantify them in order to establish their usefulness as biomarkers. MATERIALS & METHODS: We have analysed the expression of angiogenic markers VEGF and bFGF in serum and tissue specimens from 66 pituitary adenomas (43 invasive and 23 noninvasive). For serum analysis, we used xMAP and ELISA, and for tissue analysis, we performed histopathology and immunohistochemistry. RESULTS & CONCLUSION: We measured the serum angiogenic factors in pituitary adenomas. The quantification methods revealed significant differences between pituitary adenoma patients and controls, for both VEGF (212.4 vs 112.5 pg/ml in controls) and bFGF (mean value of 12.6 vs 10.8 pg/ml in controls), and also differentiated between invasive and noninvasive adenomas (p < 0.05). The tissue expression of VEGF and bFGF strongly correlated with their serum level increase. Our findings can be further developed into methods for selection of patients suitable for personalized, antiangiogenic therapy.
34
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Jonathan D. Oliner, Hosung Min, Juan Leal et al. · Cancer Cell · 2004 · 469 citations · Full text
Medicine, Cancer Biology, Oncology +14
The Epidemiology of Prolactinomas
Antonio Ciccarelli, Adrian Daly, Albert Beckers · Pituitary · 2005 · 284 citations
Christopher J. McCabe, Kristien Boelaert, Lesley Tannahill et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 216 citations · Full text
Christopher J. McCabe, J Khaira, Kristien Boelaert et al. · Clinical Endocrinology · 2003 · 159 citations